Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 30Leukemia, B-Cell 10Lymphoma 9Leukemia 8Recurrence 7Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Neoplasms 6Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Waldenstrom Macroglobulinemia 3Burkitt Lymphoma 3Lymphoma, B-Cell, Marginal Zone 2Bronchiolitis Obliterans Syndrome 2Thrombocytopenia 1Paraproteinemias 1Oncology Patients Receiving Chemotherapy 1Lymphoma, B-Cell 1Lymphocytosis 1Lymphadenopathy 1Leukemia, Prolymphocytic 1Leukemia, Lymphoid 1Fever 1Fatigue 1Agammaglobulinemia 1

Interventions

Lenalidomide 2plerixafor 1ofatumumab 1SARS-CoV-2 inactivated vaccines 1Influenza Vaccines 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Agammaglobulinemia × ofatumumab × Clear all
NCT01002755 2019-05-07

Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
36 enrolled 7 charts
Classical hematologyLymphoidOther hematologic neoplasm

Lymphadenopathy, Agammaglobulinemia, Fatigue, Fever, Lymphocytosis, Paraproteinemias, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡